Sort
23,748 grants matching “melanoma”
Immunological Monitoring & Cellular Products
$460,523Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · CA
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
$460,517Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AR
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
$460,426Walter J Storkus · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA
A novel immunotolerizing therapy for autoimmune vitiligo
$460,375Kanneganti Murthy · Radikal Therapeutics, Inc. · R44 · FY2019 · AR
Measuring nucleotide excision repair in human populations
$460,339Laura Jane Niedernhofer · University Of Minnesota · U01 · FY2018 · ES
Senescence as a Therapeutic Endpoint
$460,322Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA
Role of lipid metabolism in CD8+ T cell ferroptosis
$460,310Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA
Defining impact of in situ activation of CD40 and type 1 interferon signaling on theTME and systemic T cell immunity in murine models and cancer patients
$460,204Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Defining impact of in situ activation of CD40 and type 1 interferon signaling on theTME and systemic T cell immunity in murine models and cancer patients
$460,204Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Developmental Funds
$459,887Dario C. Altieri · Wistar Institute · P30 · FY2015 · CA
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
$459,865Eric T Ahrens · University Of California, San Diego · R01 · FY2021 · CA
Targeting macrophages in metastatic cancer
$459,802Anthony Rongvaux · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$459,794Peter Tattersall · Yale University · R01 · FY2013 · CA
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$459,704Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2018 · AR
Promoting Bim-driven apoptosis through MAPK inhibition: A therapeutic strategy in advanced melanoma
$459,563Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2020 · CA
Post-translational control of cancer cell stress response and metastasis
$459,505Iannis Aifantis · New York University School Of Medicine · R01 · FY2017 · CA
Post-translational control of cancer cell stress response and metastasis
$459,505Iannis Aifantis · New York University School Of Medicine · R01 · FY2020 · CA
Post-translational control of cancer cell stress response and metastasis
$459,505Iannis Aifantis · New York University School Of Medicine · R01 · FY2018 · CA
Sensitivity and specificity of line-scanning versus point-scanning reflectance confocal microscopy for detecting melanocytic skin lesions in vivo
$459,471Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Developmental Funds
$459,436Dario C. Altieri · Wistar Institute · P30 · FY2025 · CA
CELL SURFACE STRUCTURE AND TRANSFORMATIONS
$459,415Massachusetts Institute Of Technology · R01 · FY2001 · CA
Bifunctional Antibodies for Melanoma Therapy
$459,361Peter M Glazer · Yale University · R01 · FY2014 · CA
VEGFs in tumor lymphatic metastasis
$459,337Laura E Benjamin · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Regulation of Metastasis and Angiogenesis by Autotaxin and its Products
$459,314Mary Stracke · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$459,263Mobile Infirmary Medical Center · U10 · FY2003 · CA